Regulatory 2024-08-09 | Ascelia Pharma Announces Final Terms of Rights Issue PDF Report Presentation Webcast
Regulatory 2024-07-10 | Ascelia Pharma Carries Out a Rights Issue of Units of Approximately SEK 105 Million to Fully Finance the NDA Submission for Orviglance® PDF Report Presentation Webcast
Regulatory 2021-03-17 | Ascelia Pharma has carried out a directed new share issue raising SEK 200 million PDF Report Presentation Webcast
Regulatory 2021-03-17 | Ascelia Pharma intends to carry out a directed new share issue PDF Report Presentation Webcast
Regulatory 2020-06-30 | Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million PDF Report Presentation Webcast
Regulatory 2019-03-06 | Ascelia Pharma’s new share issue in connection with the IPO on Nasdaq Stockholm was significantly oversubscribed PDF Report Presentation Webcast
Regulatory 2018-05-16 | Ascelia Pharma has raised SEK 60 million to finalize phase III preparations for Mangoral® PDF Report Presentation Webcast
